Back

Clinicopathological and Imaging Features of Primary Biliary Cholangitis

Xie, M.; Nyabanga, C. T.; Sehmbhi, M.; Al Khalili, N.; Chon, C.; Kamath, A.; Dinani, A. M.; Weisberg, I. S.

2022-05-01 gastroenterology
10.1101/2022.04.29.22274511 medRxiv
Show abstract

Abstract/KeywordsO_ST_ABSBackground and AimsC_ST_ABSPrimary biliary cholangitis (PBC) is a chronic inflammatory autoimmune disease of the biliary epithelial cells, causing slow progression of cholestasis and fibrosis. The aim of the study is to summarize the imaging features of PBC and examine the correlation between its clinicopathological and radiologic features, elucidating the specific clinicopathological and radiologic differences between male and female PBC patients, as well as between AMA-positive and AMA-negative PBC patients. MethodsDemographic, laboratory, radiologic and survival data were collected retrospectively for patients diagnosed and treated for PBC at the Mount Sinai Health System between 2016 and 2020 with at least one ultrasound, CT, or MRI of abdomen available for assessment. Biochemical and radiologic data were compared between male v.s. female groups, and AMA-positive v.s. AMA-negative group. ResultsA total of 273 patients diagnosed with PBC were included. Non-specific hepatic parenchymal disease, cirrhosis, cholelithiasis, splenomegaly, lymphadenopathy, benign liver masses/cysts were the most common features on abdominal images. 24% of PBC patients had biliary tree abnormalities on MRI. LAD was reported in 38-47% of PBC patients. There was no significant difference in age, race, or ethnicity between the sexes of patients with PBC, however imaging characteristics of portal hypertension were more frequently seen in men. AMA-negative PBC patients had similar distributions of age, race/ethnicity and survival to AMA-positive PBC patients. ConclusionOur study summarized the clinicopathological and imaging features of PBC and distinct subgroups. This would assist in the diagnosis of PBC and avoid over-testing in real-world practice.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Hepatology Communications
22 papers in training set
Top 0.1%
22.8%
2
Hepatology
22 papers in training set
Top 0.1%
15.7%
3
PLOS ONE
5266 papers in training set
Top 18%
10.1%
4
Gut
40 papers in training set
Top 0.2%
5.0%
50% of probability mass above
5
JHEP Reports
11 papers in training set
Top 0.1%
4.2%
6
Scientific Reports
3612 papers in training set
Top 30%
3.4%
7
American Journal of Gastroenterology
17 papers in training set
Top 0.2%
2.9%
8
Journal of Hepatology
21 papers in training set
Top 0.2%
2.5%
9
Frontiers in Medicine
120 papers in training set
Top 1%
2.2%
10
Journal of Clinical Medicine
97 papers in training set
Top 2%
2.0%
11
Frontiers in Cellular and Infection Microbiology
109 papers in training set
Top 2%
1.6%
12
Vaccines
198 papers in training set
Top 2%
1.5%
13
BMJ Open
601 papers in training set
Top 10%
1.5%
14
BMC Cancer
67 papers in training set
Top 1%
1.4%
15
Journal of Clinical Pathology
15 papers in training set
Top 0.3%
1.4%
16
Cureus
68 papers in training set
Top 3%
1.2%
17
Diabetes, Obesity and Metabolism
22 papers in training set
Top 0.6%
1.2%
18
JMIRx Med
32 papers in training set
Top 1%
1.2%
19
Communications Medicine
113 papers in training set
Top 3%
1.2%
20
Medicine
31 papers in training set
Top 1%
1.2%
21
Clinical Infectious Diseases
235 papers in training set
Top 2%
1.2%
22
Frontiers in Oncology
103 papers in training set
Top 2%
1.2%
23
eLife
5828 papers in training set
Top 63%
0.9%
24
Gastro Hep Advances
11 papers in training set
Top 0.3%
0.9%
25
Heliyon
152 papers in training set
Top 7%
0.9%
26
Diagnostics
50 papers in training set
Top 2%
0.9%
27
PLOS Neglected Tropical Diseases
466 papers in training set
Top 6%
0.6%
28
Gastroenterology
42 papers in training set
Top 1%
0.6%
29
PeerJ
308 papers in training set
Top 14%
0.5%
30
Clinical and Experimental Immunology
12 papers in training set
Top 0.2%
0.5%